a near-significant trendp = 0.053
Nonetheless, a near-significant trend was observed in the overall response rate (68.6% vs. 33%; p = 0.053) and a significant decrease in Ki67 levels (75% vs. 26.7%; p = 0.021) in the subgroup of patients with HR+/HER-2+ tumors.